Assis, Rafael http://orcid.org/0000-0003-0165-8106
Jain, Aarti
Nakajima, Rie
Jasinskas, Algis
Khan, Saahir http://orcid.org/0000-0001-6732-768X
Palma, Anton
Parker, Daniel M. http://orcid.org/0000-0002-5352-7338
Chau, Anthony
Hosseinian, Sina
Vasudev, Milind
Au, Connie
Powers, Kathleen
Birring, Paramveer S.
Chin, Brandon
Andary, Rana
Obiero, Joshua M. http://orcid.org/0000-0001-9741-512X
Tifrea, Delia
Leung, Amanda
Grabar, Christina
Muqolli, Fjolla
Khalil, Ghali
Escobar, Jessica Colin http://orcid.org/0000-0002-6821-2195
Ventura, Jenny
Davies, D. Huw
Albala, Bruce
Boden-Albala, Bernadette
Schubl, Sebastian
Felgner, Philip L. http://orcid.org/0000-0002-4117-8505
,
Article History
Received: 7 June 2021
Accepted: 8 October 2021
First Online: 4 November 2021
Competing interests
: The coronavirus antigen microarray is intellectual property of the Regents of the University of California that is licensed for commercialization to Nanommune Inc. (Irvine, CA), a private company for which Philip L. Felgner is the largest shareholder and several co-authors (de Assis, Jain, Nakajima, Jasinskas, Davies, and Khan) also own shares. Nanommune Inc. has a business partnership with Sino Biological Inc. (Beijing, China) which expressed and purified the antigens used in this study. The other authors have no competing interests.